Use of protease nexin-I as an antiinflammatory
AssigneeIncyte Pharmaceuticals, Inc.
InventorRandal A. Scott
Life of this patent
Estimating the term…
Abstract
Methods and pharmaceutical compositions for treatment of inflammation and arthritis using protease nexin-I as an active ingredient are disclosed.
Claims15
A method of reducing the loss of glycosaminoglycans in connective tissue of a patient suffering from a disease which causes the loss of glycosaminoglycans from connective tissue, comprising
- administering to the patient an amount of protease nexin-I sufficient to reduce the loss of glycosaminoglycans from connective tissue.
A method of reducing inflammation comprising
- administering to the patient an amount of protease nexin-I sufficient to reduce the loss of glycosaminoglycans from connective tissue and thereby reduce inflammation.
A method of reducing inflammation and the loss of glycosaminoglycans in connective tissue of a patient suffering from arthritis, comprising administering to the patient, by injection, an amount of protease nexin-I sufficient to reduce the loss of glycosaminoglycans from connective tissue and thereby reduce inflammation.
Dependencies are inferred from the claim text.